Financial statements Opharm
Balance sheet of Opharm
Share capital:
Share capital:
1 250 000 PLN
Company deleted from KRS: 2024-11-28
Balance sheet data of OPHARM
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 50 750 760,95 | 55 163 722,93 | 43 403 330,68 |
| A. Fixed assets | 13 150 586,65 | 27 659 001,20 | 27 788 398,80 |
| B. Current assets | 37 600 174,30 | 27 504 721,73 | 15 614 931,88 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
| Total liabilities | 50 750 760,95 | 55 163 722,93 | 43 403 330,68 |
| A. Equity | 36 871 688,65 | 44 889 585,79 | 35 979 139,45 |
| B. Liabilities and provisions for liabilities | 13 879 072,30 | 10 274 137,14 | 7 424 191,23 |
| I. Long-term liabilities | 0,00 | 3 905 165,63 | 2 688 966,10 |
| II. Short-term liabilities | 11 330 408,41 | 3 454 021,36 | 2 740 660,17 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.